Cargando…

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

Ceftaroline fosamil (ceftaroline) was recently approved for the treatment of community- acquired pneumonia (CAP) and complicated skin infections. This newly developed cephalosporin possesses a broad spectrum of activity against gram-positive and gram-negative bacteria. Most importantly, ceftaroline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maselli, Diego J, Fernandez, Juan F, Whong, Christine Y, Echevarria, Kelly, Nambiar, Anoop M, Anzueto, Antonio, Restrepo, Marcos I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278208/ https://www.ncbi.nlm.nih.gov/pubmed/22355258 http://dx.doi.org/10.2147/IDR.S17433

Ejemplares similares

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Antimicrobial Treatment of Community-Acquired Pneumonia
por: Restrepo, Marcos I., et al.
Publicado: (2005)

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
por: Goodman, Julian J, et al.
Publicado: (2012)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
por: Maggiore, Christy, et al.
Publicado: (2015)

809 Contemporary Experience with Ceftaroline Fosamil for the Treatment of Community-acquired Bacterial Pneumonia
por: Johnson, Leonard B, et al.
Publicado: (2014)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
por: Mpenge, Mbiye A, et al.
Publicado: (2015)

Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE
por: Carreno, Joseph J., et al.
Publicado: (2014)

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study
por: Mortensen, Eric M, et al.
Publicado: (2008)

Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010)

Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia
por: Vazquez, Jose A., et al.
Publicado: (2015)

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2021)

A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
por: Cristinacce, Andrew, et al.
Publicado: (2019)

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2021)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Experience with ceftaroline for treatment of methicillin-resistant Staphylococcus aureus pneumonia in a community hospital
por: Karki, Apurwa, et al.
Publicado: (2017)

Ceftaroline-related acute eosinophilic pneumonia
por: Min, Zaw, et al.
Publicado: (2021)

Disparities of Care for African-Americans and Caucasians with Community-Acquired Pneumonia: A Retrospective Cohort Study
por: Frei, Christopher R, et al.
Publicado: (2010)

Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Restrepo, Marcos I., et al.
Publicado: (2018)

Community-Acquired Pneumonia, Bacterial
por: File, Thomas M.
Publicado: (2012)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

Ceftaroline-fosamil: Acute eosinophilic pneumonia: case report
Publicado: (2021)

Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial
por: Zhuo, Chao, et al.
Publicado: (2022)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
por: Meduri, G. Umberto, et al.
Publicado: (2022)

Community-acquired bacterial pneumonia in adults: An update
por: Eshwara, Vandana Kalwaje, et al.
Publicado: (2020)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017)

Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Torres, Antoní, et al.
Publicado: (2023)

A clinical pathway for community-acquired pneumonia: an observational cohort study
por: Frei, Christopher R, et al.
Publicado: (2011)

Viral and bacterial aetiology of community‐acquired pneumonia in adults
por: Huijskens, Elisabeth G. W., et al.
Publicado: (2012)

Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Approach to Common Bacterial Infections: Community-Acquired Pneumonia
por: Iroh Tam, Pui-Ying
Publicado: (2013)

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
por: Metlay, Joshua P., et al.
Publicado: (2019)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

An international perspective on hospitalized patients with viral community-acquired pneumonia
por: Radovanovic, Dejan, et al.
Publicado: (2019)

Community-acquired pneumonia: similarities and differences between European and American guidelines - A narrative review –
por: Barberán, José, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snocndtb5cdgnqaf6olnokosad